These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10499311)

  • 1. Calcific uremic arteriolopathy in association with low turnover uremic bone disease.
    Mawad HW; Sawaya BP; Sarin R; Malluche HH
    Clin Nephrol; 1999 Sep; 52(3):160-6. PubMed ID: 10499311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calciphylaxis: risk factors, diagnosis, and treatment.
    Nigwekar SU; Kroshinsky D; Nazarian RM; Goverman J; Malhotra R; Jackson VA; Kamdar MM; Steele DJ; Thadhani RI
    Am J Kidney Dis; 2015 Jul; 66(1):133-46. PubMed ID: 25960299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism.
    Matsuoka S; Tominaga Y; Uno N; Goto N; Sato T; Katayama A; Haba T; Uchida K; Kobayashi K; Nakao A
    World J Surg; 2005 May; 29(5):632-5. PubMed ID: 15827857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcific uremic arteriolopathy: a call for action.
    Brandenburg VM; Cozzolino M; Mazzaferro S
    Semin Nephrol; 2014 Nov; 34(6):641-7. PubMed ID: 25498382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates.
    Hanafusa T; Yamaguchi Y; Tani M; Umegaki N; Nishimura Y; Katayama I
    J Am Acad Dermatol; 2007 Dec; 57(6):1021-5. PubMed ID: 18021849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fatal Case of Non-Uremic Calciphylaxis: A Case Report and Literature Review.
    Abdalla AO; Al-Khafaji J; Taha M; Malik S
    Am J Case Rep; 2018 Jul; 19():804-807. PubMed ID: 29983410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calciphylaxis: a rare complication in alcoholic liver disease.
    Sermijn E; Strobbe T; Vandekerckhove L; Libbrecht L; Colle I; Schoonjans R; Vogelaers D
    Acta Clin Belg; 2013; 68(2):116-9. PubMed ID: 23967720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calciphylaxis: from the disease to the diseased.
    Oliveira TM; Frazão JM
    J Nephrol; 2015 Oct; 28(5):531-40. PubMed ID: 25835730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcific uraemic arteriolopathy (calciphylaxis): incidence, clinical features and long term outcomes].
    Esteve V; Almirall J; Luelmo J; Sáez A; Andreu X; García M
    Nefrologia; 2007; 27(5):599-604. PubMed ID: 18045036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
    Hayashi M; Takamatsu I; Kanno Y; Yoshida T; Abe T; Sato Y;
    Nephrol Dial Transplant; 2012 Apr; 27(4):1580-4. PubMed ID: 22121234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failure.
    Malluche HH; Faugère MC; Ritz E; Caillens G; Wildberger D
    Miner Electrolyte Metab; 1986; 12(2):113-8. PubMed ID: 3960014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcific uremic arteriolopathy (calciphylaxis)].
    Gauthey D; Morisod J; Coutaz M
    Rev Med Suisse; 2008 May; 4(156):1167-71. PubMed ID: 18630172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calciphylaxis: a pseudo-vasculitis syndrome.
    Kyttaris VC; Timbil S; Kalliabakos D; Vaiopoulos G; Weinstein A
    Semin Arthritis Rheum; 2007 Feb; 36(4):264-7. PubMed ID: 17276174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calciphylaxis: a devastating complication of derangements of calcium-phosphorus metabolism--a case report and review of the literature.
    Carter T; Ratnam S
    Nephrol Nurs J; 2013; 40(5):431-5; quiz 436. PubMed ID: 24308109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calciphylaxis: a case report.
    Strippoli D; Simonetti V; Russo G; Motolese A
    Dermatol Ther; 2008; 21 Suppl 3():S26-8. PubMed ID: 19076628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.